Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicVAX plus varenicline for smoking cessation
2008-005894-36Phase 2Completed
- Sponsor
- ZonMw
- Start
- Oct 2008
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing NicVAX + varenicline with Placebo + varenicline (2 arms). Primary endpoint: Long-term abstinence from Week 9 to Week 52. Started Oct 2008; status: completed.
02
Drugs
NicVAXvarenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2008-005894-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005894-36.